Fighting For Relevance, Fitbit Makes Move Into Chronic Disease Detection
Fitbit is struggling to keep itself relevant in an increasingly crowded wearable tech market. According to Business Insider, the company is playing a long game by making a big move into health. It says it's starting with features that it says will allow it to better track heart rate and align with other medical devices like blood-sugar trackers for diabetics. It's also developing tools to detect common but serious conditions such as sleep apnea and atrial fibrillation. Shelten Yuen is Fitbit's vice president of research and development. He says the company hopes its clinical trials and its involvement with a Food and Drug Administration program will enable it to make several fresh products available soon.